74
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles

, , , &
Pages 1929-1935 | Published online: 09 Sep 2011

References

  • TemperoMABerlinJDucreuxMPancreatic cancer treatment and research: An international expert panel discussionAnn Oncol2011221500150621199884
  • JemalASiegelRXuJQWardECancer Statistics, 2010CA Cancer J Clin20106027730020610543
  • NakaiYIsayamaHSasakiTComorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapyCrit Rev Oncol Hematol20117825225920579902
  • GuoQLYouQDWuZQYuanSTZhaoLGeneral gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude miceActa Pharmacol Sin20042576977415169630
  • YuJGuoQLYouQDGambogic acid-induced G(2)/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cellsCarcinogenesis20072863263817012222
  • KasibhatlaSJessenKAMaliartchoukSA role for transferrin receptor in triggering apoptosis when targeted with gambogic acidProc Natl Acad Sci U S A2005102120951210016103367
  • WuZQGuoQLYouQDZhaoLGuHYGambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cellsBiol Pharm Bull2004271769177415516720
  • ZhuXZhangCWuXLPreparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivativesDrug Dev Ind Pharm2008342918214750
  • WangJQSuiMHFanWMNanoparticles for tumor targeted therapies and their pharmacokineticsCurr Drug Metab20101112914120359289
  • ZhangHJChenBAJiangHWangCLWangHPWangXMA strategy for ZnO nanorod mediated multi-mode cancer treatmentBiomaterials2011321901914
  • ChenBAChengJShenMFMagnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsInt J Nanomedicine20094657119421371
  • ChenBAMaoPPChengJReversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cellsInt J Nanomedicine2010543744420957165
  • WuWWChenBAChengJBiocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignanciesInt J Nanomedicine201051079108421170355
  • WangJChenBAChengJApoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles coloaded with daunorubicin and 5-bromotetrandrinInt J Nanomedicine201161027103421720514
  • WangJChenBAChengJSynthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticlesInt J Nanomedicine2011620321121445276
  • ChenBALiangYQWuWWSynergistic effect of magnetic nanoparticles of Fe3O4 with gambogic acid on apoptosis of K562 leukemia cellsInt J Nanomedicine2009425125920011242
  • ZhangDWZhangHNieJYangJSynthesis and self-assembly behavior of pH-responsive amphiphilic copolymers containing ketal functional groupsPolym Int201059967974
  • BarefordLASwaanPWEndocytic mechanisms for targeted drug deliveryAdv Drug Delivery Rev200759748758
  • YooHSLeeKHOhJEParkTGIn vitro and in vivo anticancer activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release20006841943110974396
  • LinBLShenXDCuiSApplication of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release propertiesBiomed Mater2007213213418458446
  • FeckerLFGeilenCCTchernevGLoss of proapoptotic Bcl-2- related multidomain proteins in primary melanomas is associated with poor prognosisJ Invest Dermatol20061261366137116528364
  • YangEKorsmeyerSJMolecular thanatopsis: A discourse on the BCL2 family and cell deathBlood1996883864018695785
  • GhavamiSHashemiMAndeSRApoptosis and cancer: Mutations within caspase genesJ Med Genet20094649751019505876